PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases

Clinical trial NCT06380881 · COMPLETED

Trial details

NCT number: NCT06380881
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Patients With Bone Metastases

Start date: 2024-05-20
Primary completion: 2025-08-06
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.